Influenza A virus hemagglutinin H1 stalk domain (HA stalk)

The Influenza A virus hemagglutinin (HA) stalk domain is a highly conserved region of the primary surface glycoprotein responsible for viral entry into host cells. Unlike the highly plastic globular head domain, which frequently undergoes antigenic drift, the stalk domain remains relatively stable across different influenza strains and subtypes, particularly within Group 1 (including H1). Its primary biological role is to mediate the fusion of the viral envelope with the endosomal membrane of the host cell through a dramatic pH-dependent conformational change. This conservation makes the H1 stalk domain a premier target for the development of 'universal' influenza vaccines and broadly neutralizing monoclonal antibodies (bnAbs). Therapeutic strategies targeting this domain typically aim to lock the HA protein in its pre-fusion state, effectively neutralizing the virus by preventing the delivery of the viral genome. Clinical candidates such as MEDI8852 and VIS410 have demonstrated the potential for these stalk-binding agents to provide broad protection against diverse H1N1 strains, including seasonal and pandemic variants.

Other names

Hemagglutinin stem domainHA2 subunitInfluenza A virus HA stalkConserved HA stem region

Broadly neutralizing antibodies bind to the conserved stalk domain to inhibit the pH-triggered conformational change required for viral-host membrane fusion, thereby preventing the release of the viral genome into the host cell cytoplasm.